Diagnostic performance of Node-RADS on MRI for a standardized assessment of lymph node metastasis in ovarian cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Node-RADS score effectively assesses lymph node metastasis in ovarian cancer (OC). A Node-RADS score greater than 3 demonstrated satisfactory diagnostic performance for detecting OC lymph node spread.
Area Of Science
- Radiology
- Oncology
- Medical Imaging
Background
- Lymph node (LN) metastasis is crucial in ovarian cancer (OC) staging and treatment.
- Standardized assessment of LNs is needed for accurate diagnosis.
- The Node-RADS score offers a comprehensive evaluation of LNs based on size and configuration.
Purpose Of The Study
- To evaluate the diagnostic performance of the Node-RADS score for detecting lymph node metastasis in ovarian cancer patients.
- To assess the effectiveness of individual Node-RADS criteria in identifying metastatic LNs.
Main Methods
- Retrospective analysis of 81 OC patients who underwent MRI and debulking surgery.
- Node-RADS scoring applied to assess LN metastasis likelihood on MRI.
- Statistical analysis including chi-square test, Fisher's exact test, ROC curve, and AUC to evaluate diagnostic performance.
Main Results
- Textural changes within Node-RADS criteria showed the highest performance (sensitivity 84.6%, specificity 78.7%).
- Node-RADS scores >3 demonstrated high diagnostic accuracy for LN metastasis (sensitivity 73.1%, specificity 97.8%).
- Area under the curve (AUC) values were 0.869 at the patient level and 0.895 at the LN level.
Conclusions
- Node-RADS is a suitable tool for structured reporting of lymph node metastasis in ovarian cancer.
- A Node-RADS score >3 indicates a high likelihood of metastasis and provides satisfactory diagnostic performance.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.